The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Medical Devices
Shenzhen New Industries Price, Forecast, Insider, Ratings, Fundamentals & Signals
-2.19% CNY70.70
America/New_York / 30 apr 2024 @ 03:04
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 55 550 mill |
| EPS: | 2.19 |
| P/E: | 32.28 |
| Earnings Date: | May 06, 2024 |
| SharesOutstanding: | 785.72 mill |
| Avg Daily Volume: | 3.59 mill |
| RATING 2024-04-30 |
|---|
| S- |
| Strong Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Buy | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.90x |
| Company: PE 32.28 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.79x |
| Company: PE 32.28 | industry: PE 40.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY164.47 (132.64%) CNY93.77 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 67.89 - 73.51 ( +/- 3.97%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY70.70 (-2.19% ) |
| Volume | 3.98 mill |
| Avg. Vol. | 3.59 mill |
| % of Avg. Vol | 110.78 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 300832.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
300832.SZ
Shenzhen New Industries Biomedical Engineering Co., Ltd., a bio-medical company, engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals and laboratories in China and internationally. It offers immunology, clinical chemistry, and integrated systems, as well as immunoassay and clinical chemistry reagent kits. The company was founded in 1995 and is based in Shenzhen, China.